Novonix Stock Performance
| NVNXF Stock | USD 0.36 0.01 2.86% |
The company secures a Beta (Market Risk) of -0.48, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Novonix are expected to decrease at a much lower rate. During the bear market, Novonix is likely to outperform the market. At this point, Novonix has a negative expected return of -0.0196%. Please make sure to verify Novonix's value at risk, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to decide if Novonix performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Novonix has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Novonix is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 136.7 M | |
| Total Cashflows From Investing Activities | -147.4 M |
Novonix |
Novonix Relative Risk vs. Return Landscape
If you would invest 43.00 in Novonix on November 3, 2024 and sell it today you would lose (7.00) from holding Novonix or give up 16.28% of portfolio value over 90 days. Novonix is currently producing negative expected returns and takes up 7.6968% volatility of returns over 90 trading days. Put another way, 68% of traded pink sheets are less volatile than Novonix, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Novonix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novonix's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Novonix, and traders can use it to determine the average amount a Novonix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0025
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NVNXF |
Estimated Market Risk
| 7.7 actual daily | 68 68% of assets are less volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Novonix is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Novonix by adding Novonix to a well-diversified portfolio.
Novonix Fundamentals Growth
Novonix Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Novonix, and Novonix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Novonix Pink Sheet performance.
| Return On Equity | -0.26 | |||
| Return On Asset | -0.12 | |||
| Operating Margin | (7.36) % | |||
| Current Valuation | 534.72 M | |||
| Shares Outstanding | 485.95 M | |||
| Price To Book | 2.49 X | |||
| Price To Sales | 69.85 X | |||
| Revenue | 8.42 M | |||
| EBITDA | (63.54 M) | |||
| Cash And Equivalents | 207.08 M | |||
| Cash Per Share | 0.43 X | |||
| Total Debt | 52.15 M | |||
| Debt To Equity | 0.17 % | |||
| Book Value Per Share | 0.75 X | |||
| Cash Flow From Operations | (40.35 M) | |||
| Earnings Per Share | (0.06) X | |||
| Total Asset | 439.56 M | |||
About Novonix Performance
By analyzing Novonix's fundamental ratios, stakeholders can gain valuable insights into Novonix's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Novonix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Novonix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Novonix Limited develops and supplies battery materials, equipment, and services to the lithium-ion battery market in North America. Novonix Limited was incorporated in 2012 and is based in Brisbane, Australia. Novonix is traded on OTC Exchange in the United States.Things to note about Novonix performance evaluation
Checking the ongoing alerts about Novonix for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Novonix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Novonix generated a negative expected return over the last 90 days | |
| Novonix has high historical volatility and very poor performance | |
| Novonix has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 8.42 M. Net Loss for the year was (71.44 M) with profit before overhead, payroll, taxes, and interest of 5.41 M. | |
| Novonix has accumulated about 207.08 M in cash with (40.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.43, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 28.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Novonix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Novonix's stock is overvalued or undervalued compared to its peers.
- Examining Novonix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Novonix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Novonix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Novonix's pink sheet. These opinions can provide insight into Novonix's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Novonix Pink Sheet analysis
When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stocks Directory Find actively traded stocks across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |